We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Infosys
INFY
$49.1B
| $559K | 0.02% |
22,375
-556
| -2% | -$13.2K |
2016 Q4
21 quarters
|
|
402
Otis Worldwide
OTIS
$26.8B
| $555K | 0.02% |
7,143
-330
| -4% | -$26.4K |
2020 Q2
7 quarters
|
|
403
Advance Auto Parts
AAP
$2.65B
| $554K | 0.02% |
2,616
-242
| -8% | -$53.2K |
2016 Q4
21 quarters
|
|
404
Unilever
UL
$139B
| $554K | 0.02% |
10,653
-4,661
| -30% | -$259K |
2016 Q4
21 quarters
|
|
405
Ross Stores
ROST
$75B
| $551K | 0.02% |
5,955
+578
| +11% | +$55.1K |
2016 Q4
21 quarters
|
|
406
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.5B
| $549K | 0.02% |
6,978
+1,297
| +23% | +$100K |
2016 Q4
21 quarters
|
|
407
PNC Financial Services
PNC
$85.7B
| $540K | 0.02% |
2,832
-408
| -13% | -$82.5K |
2016 Q4
21 quarters
|
|
408
Coastal Financial
CCB
$657M
| $537K | 0.02% |
11,596
-199
| -2% | -$9.68K |
2019 Q1
12 quarters
|
|
409
DELISTED
ChemoCentryx, Inc.
CCXI
| $534K | 0.02% |
21,340
+21,000
| +6,176% | +$590K |
2021 Q3
2 quarters
|
|
410
HP
HPQ
$27.8B
| $533K | 0.02% |
13,719
-1,271
| -8% | -$46.9K |
2016 Q4
21 quarters
|
|
411
Aflac
AFL
$59.2B
| $530K | 0.02% |
8,090
+140
| +2% | +$8.77K |
2016 Q4
21 quarters
|
|
412
FedEx
FDX
$69.9B
| $529K | 0.02% |
2,247
-128
| -5% | -$30.1K |
2016 Q4
21 quarters
|
|
413
CBRE Group
CBRE
$39.2B
| $524K | 0.02% |
5,653
-162
| -3% | -$15.8K |
2016 Q4
21 quarters
|
|
414
Fifth Third Bancorp
FITB
$45.7B
| $523K | 0.02% |
11,813
+1,872
| +19% | +$87.4K |
2016 Q4
21 quarters
|
|
415
ChipMOS TECHNOLOGIES
IMOS
$2.26B
| $521K | 0.02% |
14,622
-583
| -4% | -$20.3K |
2017 Q4
17 quarters
|
|
416
iShares Biotechnology ETF
IBB
$10.6B
| $518K | 0.02% |
3,957
-324
| -8% | -$42.2K |
2016 Q4
21 quarters
|
|
417
Rambus
RMBS
$10.1B
| $517K | 0.02% |
16,007
+50
| +0.3% | +$1.38K |
2019 Q3
10 quarters
|
|
418
Royal Bank of Canada
RY
$272B
| $517K | 0.02% |
4,609
-319
| -6% | -$35.8K |
2016 Q4
21 quarters
|
|
419
Insulet
PODD
$9.62B
| $516K | 0.02% |
1,958
-14
| -0.7% | -$3.44K |
2018 Q3
14 quarters
|
|
420
Occidental Petroleum
OXY
$60.6B
| $514K | 0.02% |
8,936
+527
| +6% | +$23.3K |
2016 Q4
21 quarters
|
|
421
UiPath
PATH
$7.15B
| $513K | 0.02% |
17,675
-11
| -0.1% | -$371 |
2021 Q2
3 quarters
|
|
422
KKR & Co
KKR
$78.7B
| $511K | 0.02% |
8,620
+8,242
| +2,180% | +$519K |
2020 Q2
7 quarters
|
|
423
iShares US Energy ETF
IYE
$1.74B
| $510K | 0.02% |
12,302
-1,471
| -11% | -$54.2K |
2018 Q4
13 quarters
|
|
424
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.3B
| $509K | 0.02% |
12,986
-1,056
| -8% | -$42.5K |
2019 Q2
11 quarters
|
|
425
Cintas
CTAS
$84.6B
| $508K | 0.02% |
4,700
-140
| -3% | -$13.6K |
2016 Q4
21 quarters
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.